PREMIO COLLAB

PREMIO COLLAB is dedicated to revolutionizing patient care and clinical workflows within the oncology sector through advanced response monitoring. As a leading consortium, PREMIO COLLAB unites experts in a mission to enhance the survival and quality of life for metastatic breast cancer (MBC) patients. By integrating cutting-edge technology and a patient-centric approach, PREMIO COLLAB is at the forefront of modernizing cancer treatment.

The vision of PREMIO COLLAB is to challenge outdated practices and incorporate the patient's perspective into clinical trials. Through a multicentre RCT comparing FDG-PET/CT monitoring with conventional CT, PREMIO COLLAB focuses on survival rates, quality of life improvements, and cost-effectiveness. The incorporation of AI and participatory research ensures that patient pathways are modern and effective. This innovative approach sets PREMIO COLLAB apart as a key player in the fight against cancer.

As a hub of interdisciplinary collaboration, PREMIO COLLAB is shaping the future of oncology by integrating AI in imaging and biopsies, and crafting modern digital workflows. PREMIO COLLAB’s work is pivotal for health policy, underpinning new clinical standards in MBC management. Join PREMIO COLLAB on its journey to redefine oncology and improve patient outcomes. To further explore collaboration opportunities and showcase your products, we invite the manager of PREMIO COLLAB to create a customized and exclusive company showcase and product listing on our platform.